Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Erwin

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Diagnostic Microbiology and Infectious Disease|June 1, 1997
In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporinM E Erwin, D Varnam, R N Jones
Diagnostic Microbiology and Infectious Disease|February 12, 1998
Avoparcin, a glycopeptide used in animal foods: antimicrobial spectrum and potency tested against human isolates from the United StatesM G Cormican, M E Erwin, R N Jones
Journal of Clinical Microbiology|January 5, 2000
Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applicationsB A Odland, M E Erwin, R N Jones
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniaeM G Cormican, M E Erwin, R N Jones
Diagnostic Microbiology and Infectious Disease|February 1, 1994
Interpretive criteria for DU-6859a disk diffusion tests using 5-micrograms disksR N Jones, D M Johnson, M E Erwin
Diagnostic Microbiology and Infectious Disease|October 1, 1993
Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeaeM S Barrett, R N Jones, M E Erwin
International Journal of Antimicrobial Agents|August 5, 2000
Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areasR N Jones, M A Pfaller, M E Erwin
Diagnostic Microbiology and Infectious Disease|July 1, 1993
In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolonesD M Johnson, R N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|May 1, 1994
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study GroupM J Bale, R N Jones, M E Erwin
Journal of Clinical Microbiology|October 1, 1993
Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganiiD J Biedenbach, R N Jones, M E Erwin
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Diagnostic Microbiology and Infectious Disease|June 1, 1997
In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporinM E Erwin, D Varnam, R N Jones
Diagnostic Microbiology and Infectious Disease|February 12, 1998
Avoparcin, a glycopeptide used in animal foods: antimicrobial spectrum and potency tested against human isolates from the United StatesM G Cormican, M E Erwin, R N Jones
Journal of Clinical Microbiology|January 5, 2000
Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applicationsB A Odland, M E Erwin, R N Jones
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniaeM G Cormican, M E Erwin, R N Jones
Diagnostic Microbiology and Infectious Disease|February 1, 1994
Interpretive criteria for DU-6859a disk diffusion tests using 5-micrograms disksR N Jones, D M Johnson, M E Erwin
Diagnostic Microbiology and Infectious Disease|October 1, 1993
Interpretive criteria for cefodizime in vitro susceptibility tests with Neisseria gonorrhoeaeM S Barrett, R N Jones, M E Erwin
International Journal of Antimicrobial Agents|August 5, 2000
Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areasR N Jones, M A Pfaller, M E Erwin
Diagnostic Microbiology and Infectious Disease|July 1, 1993
In vitro antimicrobial activity of CP-99433 compared with other fluoroquinolonesD M Johnson, R N Jones, M E Erwin
Diagnostic Microbiology and Infectious Disease|May 1, 1994
Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study GroupM J Bale, R N Jones, M E Erwin
Journal of Clinical Microbiology|October 1, 1993
Interpretive accuracy of the disk diffusion method for testing newer orally administered cephalosporins against Morganella morganiiD J Biedenbach, R N Jones, M E Erwin
Pageof 9